KRISTIN R DRYER ACNP NPI 1326353517

NPI Information

  • NPI: 1326353517
  • Provider Name: KRISTIN R DRYER, ACNP
  • Classification: Nurse Practitioner - 363L00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 13400 E SHEA BLVD
    SCOTTSDALE, AZ
    ZIP 85259
  • Phone: (480) 301-8000

Map and Directions

Get Directions

NPI Details

Kristin R Dryer, ACNP is a nurse practitioner in Scottsdale, AZ with 16 years of experience. The provider is (1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners. Kristin R Dryer, ACNP NPI is 1326353517. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

13400 E SHEA BLVD
SCOTTSDALE, AZ
ZIP 85259-499
Phone: (480) 301-8000

The NPI 1326353517 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, belatacept, 1 mg (HCPCS:J0485)
  • Injection, vedolizumab, 1 mg (HCPCS:J3380)
  • Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, ocrelizumab, 1 mg (HCPCS:J2350)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, eptinezumab-jjmr, 1 mg (HCPCS:J3032)
  • Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS:J1442)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, remdesivir, 1 mg (HCPCS:J0248)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, infliximab-axxq, biosimilar, (avsola), 10 mg (HCPCS:Q5121)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Transfusion of blood or blood products (HCPCS:36430)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ertapenem sodium, 500 mg (HCPCS:J1335)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, vancomycin hcl, 500 mg (HCPCS:J3370)
  • Collection of blood sample from central venous tube (HCPCS:36592)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection, furosemide, up to 20 mg (HCPCS:J1940)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Ringers lactate infusion, up to 1000 cc (HCPCS:J7120)
  • Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Declotting of central venous tube (HCPCS:36593)

The enumeration date for this NPI number is 8/11/2010 and was last updated on 1/5/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1363L00000XNurse PractitionerAP5633ARIZONAYes
2363LA2100XNurse PractitionerAcute Care0024168795VIRGINIANo
3363LA2100XNurse PractitionerAcute CareAP5633ARIZONANo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.